TC
INSM icon

TFS Capital’s Insmed INSM Stock Holding History

TFS Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-13,907
Closed -$137K – 858
2016
Q2 		$137K Buy
+13,907
New +$162K 0.03% 814
2016
Q1 		– Sell
-43,146
Closed -$783K – 1044
2015
Q4 		$783K Buy
+43,146
New +$760K 0.08% 338
2015
Q2 		– Sell
-15,170
Closed -$316K – 997
2015
Q1 		$316K Buy
+15,170
New +$267K 0.03% 662
2014
Q3 		– Sell
-20,193
Closed -$403K – 1121
2014
Q2 		$403K Buy
+20,193
New +$299K 0.03% 724

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TFS Capital's INSM Position: Q3 2016 in Review

TFS Capital sold out of Insmed (INSM) in Q3 2016, closing a stake of 13,907 shares — an estimated $137K sold.

TFS Capital first reported a position in INSM in Q2 2014 and held it in 4 quarters. The position peaked at $783K in Q4 2015. 99 funds tracked by Wall St. Rank hold INSM as of Q3 2016.

  • TFS Capital reported no remaining Insmed position as of Q3 2016 after selling out during the quarter.
  • TFS Capital sold 13,907 Insmed shares in Q3 2016, an estimated $137K.
  • TFS Capital first reported a position in Insmed in Q2 2014 and held it in 4 quarters.
  • TFS Capital's Insmed position peaked at $783K in Q4 2015.
  • 99 funds tracked by Wall St. Rank held Insmed as of Q3 2016.

Based on TFS Capital's 13F filing for Q3 2016, filed 10 Nov 2016.